Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
1.790
+0.080 (4.68%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $12.52 million as of April 23, 2025. Its market cap has decreased by -29.67% in one year.
Market Cap
12.52M
Enterprise Value
51.16M
1-Year Change
-29.67%
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has decreased from $110.60M to $12.52M, a decrease of -88.68%. That is a compound annual growth rate of -18.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 12.00M | -22.58% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.15B |
| UnitedHealth Group | 395.13B |
| Johnson & Johnson | 373.94B |
| AbbVie | 310.44B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 224.49B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |